BVF as of Dec. 31, 2014
Portfolio Holdings for BVF
BVF holds 31 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 15.2 | $78M | 5.1M | 15.32 | |
| Chemocentryx | 11.4 | $59M | 8.6M | 6.83 | |
| Array BioPharma | 10.8 | $56M | 12M | 4.73 | |
| Ligand Pharmaceuticals In (LGND) | 8.9 | $46M | 860k | 53.21 | |
| Oncomed Pharmaceuticals | 5.8 | $30M | 1.4M | 21.76 | |
| Oncothyreon | 5.1 | $26M | 14M | 1.90 | |
| Five Prime Therapeutics | 4.3 | $22M | 826k | 27.00 | |
| Forward Pharma A/s | 4.3 | $22M | 1.1M | 20.83 | |
| Cytokinetics (CYTK) | 3.8 | $20M | 2.4M | 8.01 | |
| Exelixis Inc cnv | 3.5 | $18M | 31M | 0.58 | |
| Targacept | 3.4 | $18M | 6.7M | 2.63 | |
| Concert Pharmaceuticals I equity | 3.1 | $16M | 1.2M | 13.32 | |
| Loxo Oncology | 2.7 | $14M | 1.2M | 11.75 | |
| Vitae Pharmaceuticals | 2.4 | $13M | 754k | 16.64 | |
| Xenon Pharmaceuticals (XENE) | 2.4 | $12M | 618k | 19.75 | |
| Qlt | 2.1 | $11M | 2.7M | 4.01 | |
| Array Biopharma Inc note 3.000% 6/0 | 1.6 | $8.5M | 9.0M | 0.94 | |
| GTx | 1.6 | $8.1M | 11M | 0.73 | |
| Sunesis Pharmaceuticals | 1.6 | $8.0M | 3.1M | 2.55 | |
| Exelixis (EXEL) | 1.2 | $6.0M | 4.2M | 1.44 | |
| ArQule | 1.1 | $5.8M | 4.7M | 1.22 | |
| Mast Therapeutics | 0.8 | $4.1M | 7.3M | 0.56 | |
| OncoGenex Pharmaceuticals | 0.6 | $3.1M | 1.4M | 2.29 | |
| Biolinerx Ltd-spons | 0.5 | $2.4M | 1.5M | 1.62 | |
| Kalobios Pharmaceuticals | 0.4 | $2.0M | 1.2M | 1.73 | |
| Achaogen | 0.3 | $1.8M | 137k | 13.05 | |
| Regado Biosciences | 0.3 | $1.7M | 1.9M | 0.91 | |
| Biota Pharmaceuticals | 0.2 | $976k | 436k | 2.24 | |
| Aptose Biosciences | 0.2 | $987k | 167k | 5.92 | |
| Anthera Pharmaceutcls | 0.2 | $884k | 560k | 1.58 | |
| Sophiris Bio | 0.1 | $573k | 1.1M | 0.54 |
